Detalhe da pesquisa
1.
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
Blood
; 141(26): 3153-3165, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130030
2.
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors.
Cancer Immunol Res
; 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38869428
3.
Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures.
STAR Protoc
; 4(1): 101954, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607811
4.
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction.
bioRxiv
; 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747791
5.
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19.
Nat Commun
; 13(1): 3367, 2022 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690611
6.
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.
Blood Adv
; 6(20): 5634-5640, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858291